We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Detecto

ResMed

ResMed offers medical devices and cloud-based software applications for the diagnoses, treatment and management of sl... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

CPAP Tracker App Increases Treatment Compliance Rates

By HospiMedica International staff writers
Posted on 31 Aug 2016
Print article
Image: Screenshots of the myAir application (Photo courtesy of ResMed).
Image: Screenshots of the myAir application (Photo courtesy of ResMed).
A new, easy-to-use online app for sleep apnea patients helps them achieve optimum continuous positive airway pressure (CPAP) therapy.

The ResMed (San Diego, CA, USA) myAir application delivers a daily “myAir score” to users every morning, showing how long they slept on CPAP, how many apneas they had per hour, and how well their CPAP mask fit. The app also provides personalized tips for greater comfort and sleep, and badges when users reach milestones in their therapy. The data can also help doctors and care providers sort and prioritize support concerns, and also know who is doing well with their CPAP compliance.

Compliant CPAP is key for patients to effectively treat their obstructive sleep apnea (OSA), and according to a company statement, 84% of myAir users are compliant on CPAP within 90 days, compared to an average 50% compliant rate achieved by CPAP users without the app. The myAir web application, which is compatible with the ResMed Air10, AirSense, and AirCurve machines, is currently available only for iPhone or other Apple devices users. Roughly 900 patients a day are signing up for the service.

“We have seen increased rates of patient engagement and satisfaction by integrating myAir into their treatment plans,” said Raj Sodhi, president of healthcare informatics at ResMed. “Now it’s even easier for patients to engage with their therapy, thanks to the added convenience of an iPhone app.”

“myAir helps my patients be more engaged with their therapy and achieve better health outcomes,” said Jennifer Wilkymacky-Wormald, clinical and marketing manager for ATI CPAP Solutions (Crestview Hills, KY, USA). “Plus, it helps our office run more efficiently. The more patients who achieve CPAP compliance, the more time we have to focus on patients who still need extra support.”

Sleep apnea is a condition of chronic airway obstruction during sleep, potentially leading to high blood pressure, cardiovascular disease, memory problems, weight gain, impotency, and headaches. Major include obstructive sleep apnea (OSA), frequently found in obese and aged individuals with low muscle tone and excessive soft tissue around the airway; central apnea, an imbalance in the brain’s respiratory control center that leads to a delayed neurological response to carbon dioxide (CO2) blood levels; and mixed apnea, a combination of both. CPAP is the most commonly prescribed treatment, involving a mask worn during sleep that pumps air to help prevent the airway from closing.

Related Links:
ResMed

Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
New
Digital Video Colposcope
CS6/CS6 Pro
New
Mechanical Ventilator
NKV-550 Series
New
Portable Finger Pulse Oximeter
Onyx Vantage 9590

Print article

Channels

AI

view channel
Image: A novel research study moves the needle on predicting coronary artery disease (Photo courtesy of Pexels)

AI-Enabled ECG Analysis Predicts Heart Attack Risk Nearly as well as CT Scans

Increased coronary artery calcium is a marker of coronary artery disease that can lead to a heart attack. Traditionally, CT scans are used to diagnose buildup of coronary artery calcium, although CT scanners... Read more

Critical Care

view channel
Image: The new biomaterial heals tissues from the inside out (Photo courtesy of UC San Diego)

Groundbreaking Biomaterial Injected Intravenously Repairs Cells and Tissue Damaged by Heart Attack and TBI

Following a heart attack, there is development of scar tissue, which affects muscle function and can result in congestive heart failure. However, there is still no established treatment available for repairing... Read more

Surgical Techniques

view channel
Image: The neuro-chip with soft implantable electrodes could manage brain disorders (Photo courtesy of EPFL)

Implantable Neuro-Chip Uses Machine Learning Algorithm to Detect and Treat Neurological Disorders

Using a combination of low-power chip design, machine learning algorithms, and soft implantable electrodes, researchers have produced a neural interface that can identify and suppress symptoms of different... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.